Back to list

NIAAA Study of Binge Drinking

University of North Carolina at Chapel Hill


The University of North Carolina at Chapel Hill is seeking volunteers for a research study testing the efficacy of the FDA approved medication bupropion in reducing binge drinking episodes. Bupropion is currently used to treat depression, but recently, studies have suggested that bupropion might be helpful in the treatment of binge drinking. The study will be "blinded" which means that neither you nor the study staff will know if you are taking bupropion or placebo. Participants will take the study medication for 3 months and attend 10 visits.


Alcohol Abuse


Drug or Biologic



18 - 44 years


Study Population

Adults - Alcohol Use


James Garbutt
Psychiatry - General

For questions, contact:

Terry Edwards
(919) 966-0011
Visit Website

Recruitment Period End

July 1, 2019


Primary Location
Carolina Crossing
2218 Nelson Hwy, Chapel Hill, NC 27517, USA
Secondary Location
UNC Hospitals
101 Manning Dr, Chapel Hill, NC 27514, USA

Study Qualifications

Gender Any

Age Range 18 - 44 years

Participant qualification(s) Drinking a minimum of 5 binge episodes per month for males and 3 for females, Express a desire to reduce alcohol consumption or to achieve abstinence

Not eligible if: Pregnant women and women of childbearing potential who don't use birth control, Other substance abuse or dependence disorder other than nicotine or cannabis

Number of Visits

    » 10 In person visit(s)

    1 Screening, 9 Clinic

    » 2 Remote visit(s)

    2 Phone

Participation Period

3 months



By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.